Quick Answer
Fuse Medical, Inc. reported Revenue From Contract With Customer Excluding Assessed Tax of $18.64 million for the year ending 2022.
- Fuse Medical, Inc. showed a decrease of -8.7% in Revenue From Contract With Customer Excluding Assessed Tax from 2021 to 2022.
- This data is from Fuse Medical, Inc.'s annual report (Form 10-K), filed with the SEC on April 14, 2023.
- XBRL data for this metric is available from 2018 to 2022 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2018: $5.72 million | Q3 2018: $6.78 million | Q1 2019: $4.77 million | Q2 2019: $5.08 million | Q3 2019: $5.72 million | Q1 2020: $4.64 million | Q2 2020: $4.01 million | Q3 2020: $5.74 million | Q1 2021: $4.44 million | Q2 2021: $5.67 million | Q3 2021: $4.25 million | Q1 2022: $4.55 million | Q2 2022: $4.67 million | Q3 2022: $4.54 million | Q1 2023: $3.98 million | Q2 2023: $5.00 million.
- Over the full 5 years of available data (2018 to 2022), Fuse Medical, Inc.'s Revenue From Contract With Customer Excluding Assessed Tax has declined by 29.2%.
- Historical annual values: Fiscal year 2022: $18.64 million | Fiscal year 2021: $20.41 million | Fiscal year 2020: $21.40 million | Fiscal year 2019: $22.90 million | Fiscal year 2018: $26.34 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: